LESLIE WILLIAMS: Open Payments
NPI 1912612060 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 58 payments from 14 companies in 2025. Trend: 2023 $1,491 · 2024 $1,304 · 2025 $1,338
Food & beverage: $1,164Education: $174
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $462 |
| Janssen Biotech, Inc. | 7 | $242 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $148 |
| Sumitomo Pharma America, Inc. | 3 | $84 |
| Celltrion USA Inc. | 4 | $78 |
| Gilead Sciences, Inc. | 3 | $66 |
| PFIZER INC. | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Ardelyx, Inc. | 2 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
Products named: SKYRIZI, TREMFYA, ENTYVIO, GEMTESA, VEGZELMA, DUPIXENT, CREON, IBSRELA.
Industry payments across VA — which companies pay providers there.
